drugset / Trial / NCT02484950

Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair

NCT02484950

Completed 62 enrolled Rush University Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to compare the clinical outcomes of arthroscopic rotator cuff repair with and without augmentation of mesenchymal stem cells (MSCs). Mesenchymal stem cells promote tissue regeneration by differentiating into adult cell lines and by supplying growth factors to their implanted environment. They have been shown to be effective in improving both overall healing and tendon integrity in rotator cuff repair. This study will follow 100 patients in the United States and track their clinical outcomes for at least one year post-operatively.

Timeline

Start
2015-11-15
Primary completion
2024-05-01
Completion
2024-06-27

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy 6 ml Other

Indications